Ricardo A. Cordova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ricardo A. Cordova has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Angela J. Klunk
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana
134 shared publications - Kirk A. Staschke
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine
134 shared publications - Christopher Rupert
Division of Hematology and Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York
133 shared publications - Li Shen
Division of Hematology and Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York
133 shared publications - Roberto Pili
Division of Hematology and Oncology, Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA
133 shared publications - Sabrina Orsi
Division of Hematology and Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York
133 shared publications
Latest Publications
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary File 2 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Antibodies used for immunoblotting and IHC and primer sequences for qPCR primers
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 2 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Antibodies used for immunoblotting and IHC and primer sequences for qPCR primers
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary File 1 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Diet information and metabolite measurements from B6MyC-CaP tumors
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 1 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Diet information and metabolite measurements from B6MyC-CaP tumors
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary File 3 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Differentially expressed genes from RNAseq of B6MyC-CaP tumors, IPA upstream regulator analysis and AR-dependent genes, IPA metabolic and signaling pathways, and rat probasin promoter region containing ARE
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 3 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Differentially expressed genes from RNAseq of B6MyC-CaP tumors, IPA upstream regulator analysis and AR-dependent genes, IPA metabolic and signaling pathways, and rat probasin promoter region containing ARE
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
PCa tumors prepared from mice treated with ADF diet, ENZ, or ADF diet + ENZ display no cell death
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
PCa tumors prepared from mice treated with ADF diet, ENZ, or ADF diet + ENZ display no cell death
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Effect of ENZ, ADF, and ADF + ENZ on metabolic and signaling pathways in B6MyC-CaP tumors
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Effect of ENZ, ADF, and ADF + ENZ on metabolic and signaling pathways in B6MyC-CaP tumors
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
ADF reduces mTORC1 and AKT signaling, activates AMPK, and induces SIRT1 expression in PCa xenograft models
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
ADF reduces mTORC1 and AKT signaling, activates AMPK, and induces SIRT1 expression in PCa xenograft models
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Epidemiologic studies suggest that diet can affect the incidence, progression, and response to treatment in multiple cancers, including prostate cancer. In this study, we investigated the use of dietary interventions, specifically caloric or protein restriction, in combination with antiandrogen therapy as a treatment for prostate cancer. Caloric restriction through alternate-day fasting (ADF) reduced androgen receptor (AR) expression and signaling. This reduction in AR enhanced the antitumor activity of the AR antagonist enzalutamide in multiple mouse models of prostate cancer. Mechanistic studies revealed that nutrient starvation via ADF predominantly decreased AR mRNA translation at the elongation stage due to AA limitation. Pharmacologic agents that similarly impair translation elongation and promote ribosome collisions mimicked the AR translation reduction observed with ADF. Overall, these findings suggest that AA limitation through ADF impairs translation elongation in prostate cancer, to which AR mRNA translation is susceptible, leading to a reduction in AR protein levels and enhancing AR-targeted therapy.Significance:Fasting-induced caloric restriction reduces androgen receptor translation and enhances the activity of enzalutamide, suggesting that dietary intervention could be an effective strategy to enhance prostate cancer sensitivity to antiandrogen therapy.See related commentary by Anzules et al., p. 4045
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Epidemiologic studies suggest that diet can affect the incidence, progression, and response to treatment in multiple cancers, including prostate cancer. In this study, we investigated the use of dietary interventions, specifically caloric or protein restriction, in combination with antiandrogen therapy as a treatment for prostate cancer. Caloric restriction through alternate-day fasting (ADF) reduced androgen receptor (AR) expression and signaling. This reduction in AR enhanced the antitumor activity of the AR antagonist enzalutamide in multiple mouse models of prostate cancer. Mechanistic studies revealed that nutrient starvation via ADF predominantly decreased AR mRNA translation at the elongation stage due to AA limitation. Pharmacologic agents that similarly impair translation elongation and promote ribosome collisions mimicked the AR translation reduction observed with ADF. Overall, these findings suggest that AA limitation through ADF impairs translation elongation in prostate cancer, to which AR mRNA translation is susceptible, leading to a reduction in AR protein levels and enhancing AR-targeted therapy.Significance:Fasting-induced caloric restriction reduces androgen receptor translation and enhances the activity of enzalutamide, suggesting that dietary intervention could be an effective strategy to enhance prostate cancer sensitivity to antiandrogen therapy.See related commentary by Anzules et al., p. 4045
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Transcriptome analyses of B6MyC-CaP treated with ENZ, ADF, or ADF + ENZ
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
Transcriptome analyses of B6MyC-CaP treated with ENZ, ADF, or ADF + ENZ
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
ADF activates GCN2 and induces the SAPK pathway in B6MyC-CaP tumors
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
ADF activates GCN2 and induces the SAPK pathway in B6MyC-CaP tumors
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
ADF has no effect on the pharmacokinetics of ENZ
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation
ADF has no effect on the pharmacokinetics of ENZ